相似文献
1
[Management of lymphoma with respect to pathologic classification: updates and controversies].
Zhonghua Bing Li Xue Za Zhi. 2009 Nov;38(11):724-7.
2
[Diffuse large B-cell lymphoma following nodular lymphocyte predominant Hodgkin's lymphoma: report of a case].
Zhonghua Bing Li Xue Za Zhi. 2010 Sep;39(9):635-6.
3
BEACOPP escalated and rituximab in the treatment of Hodgkin lymphoma occurring concurrently with diffuse large B-cell non-Hodgkin lymphoma.
Leuk Lymphoma. 2013 Sep;54(9):2081-2. doi: 10.3109/10428194.2012.762514. Epub 2013 Feb 1.
4
Hodgkin's lymphoma--the great teacher.
N Engl J Med. 2011 Jul 21;365(3):264-5. doi: 10.1056/NEJMe1104576.
5
Gray zone lymphoma with features intermediate between classical Hodgkin lymphoma and diffuse large B-cell lymphoma: characteristics, outcomes, and prognostication among a large multicenter cohort.
Am J Hematol. 2015 Sep;90(9):778-83. doi: 10.1002/ajh.24082.
6
[Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].
Clin Ter. 2001 May-Jun;152(3):203-6.
7
High-risk diffuse large B-cell lymphoma: can we do better than rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone?
Leuk Lymphoma. 2013 Dec;54(12):2575-6. doi: 10.3109/10428194.2013.796059. Epub 2013 May 21.
8
Autoimmune hemolytic anemia and classical Hodgkin lymphoma: a case report and literature review.
Clin Adv Hematol Oncol. 2012 Apr;10(4):270-6.
9
A treatment for activated B-cell-like DLBCL?
Lancet Oncol. 2014 Aug;15(9):916-7. doi: 10.1016/S1470-2045(14)70327-4. Epub 2014 Jul 17.
10
New developments in the management of diffuse large B-cell lymphoma.
Hematology. 2012 Apr;17 Suppl 1:S93-7. doi: 10.1179/102453312X13336169156014.
Zotero 插件